Search Results - "Ntentas, G."

Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015–2023 by Holt, F., Ivanova, A., Wang, Z., Darby, S., Duane, F., Ntentas, G., Oliveros, S., Lavery, B., Shah, K., Eichholz, A., Dodwell, D., Taylor, C.

“…Breast cancer radiotherapy can increase the risks of heart disease, lung cancer and oesophageal cancer. At present, the best dosimetric predictors of these…”
Get full text

Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma by Jones, D.A., Candio, P., Shakir, R., Ramroth, J., Wolstenholme, J., Gray, A.M., Cutter, D.J., Ntentas, G.

“…Radiotherapy for Hodgkin lymphoma leads to the irradiation of organs at risk (OAR), which may confer excess risks of late effects. Comparative dosimetry…”
Get full text

Developing CAR‐T‐sparing Radiotherapy ‐ early dosimetric results by Mikhaeel, N. G., Ntentas, G., Sivabalasingham, S., Brady, J. L., Tait, J., Farias, M. Correia, Roddie, C., Sanderson, R., Kuhnl, A.

Get full text

PO-0829: Calculating dose distributions in cone beam CT for head and neck adaptive radiotherapy by Ntentas, G, Thomas, C, Greener, T

Get full text

EP-1735: Hounsfield unit variation with changing acquisition parameters for Elekta cone-beam computed tomography by Thomas, C, Ntentas, G, Greener, A

Get full text

SP-0681 Justification and dose optimisation in IGRT practices by Ntentas, G.

Get full text

OC-0059: A radiation dose-response relationship for risk of heart failure in survivors of Hodgkin lymphoma by Aleman, B.M.P, Van Nimwegen, F.A, Ntentas, G, Darby, S.C, Schaapveld, M, Hauptmann, M, Lugtenburg, P.J, Janus, C.P.M, Krol, A.D.G, Van Leeuwen, F.E, Cutter, D.J

Get full text

PREDICTED CARDIAC AND SECOND CANCER RISKS IN HODGKIN LYMPHOMA PATIENTS TREATED WITH ADVANCED PROTON BEAM THERAPY COMPARED TO PHOTON RADIOTHERAPY by Ntentas, G., Dedeckova, K., Andrilik, M., Aznar, M.C., George, B., Darby, S., Cutter, D.

Get full text

OC-0292 Estimating risk of radiation toxicity for lymphoma patients using pre-chemotherapy PET-CT scans by Shakir, R., Butterworth, V., Ramroth, J., Cutter, D., Ntentas, G.

Get full text

PO-1972 DIBH for mediastinal lymphoma: Implementation and evaluation of a 5-year service by Jones, K., Webster, A., Ntentas, G., Brady, J., Mikhaeel, N.G.

Get full text

PO-1858 Dosimetric and volumetric effects of end expiration breath hold radiotherapy for oesophageal cancer by Mayhew, C., Venkatasai, J., Khan, M., Leung, B., Owczarczyk, K., Ntentas, G.

Get full text

Detection of Early Cardiotoxicity after Anthracyclines and Mediastinal Radiotherapy Using Cardiac PET/MRI by Ntentas, G., Nazir, M.S., Reyes, E., Owczarczyk, K., Crawley, R., Smith, D., Ahmad, S., Qureshi, A., Brady, J.L., Reading, I., Marber, M., Barrington, S., Mikhaeel, G.

“…Anthracyclines (AC) or mediastinal radiotherapy (RT) are associated with cardiotoxicity. However, limited imaging studies examine early changes (<1yr) or their…”
Get full text

Developing Blood Sparing Radiotherapy Following CAR T for Lymphoma by Ntentas, G., Beekman, C., Paganetti, H., Sivabalasingham, S., Brady, J.L., Keshwani, K., Woodward, J., Sanderson, R., Roddie, C., Grassberger, C., Begum, R., Patel, M., Kuhnl, A., Mikhaeel, G.

“…Radiotherapy (RT) is an effective treatment for residual lymphoma early after CD19 chimeric antigen receptor T cell therapy (CAR T). However, there are…”
Get full text

PO-1082 Predicted cardiac and second cancer risks following treatment for Hodgkin lymphoma in Ireland by Houlihan, O., Ntentas, G., Cutter, D.J., Daly, P., Gillham, C., McArdle, O., Duane, F.K.

Get full text

PO-1128 Oesophagus exposure in breast cancer radiotherapy: systematic review of oesophageal doses 2010-2020 by Duane, F., Kerr, A., Aznar, M., Wang, Z., Ntentas, G., Darby, S., Taylor, C.

Get full text

Results of a Comprehensive Prospective Protocol of Radiotherapy Bridging and Consolidation for CAR T in Large B Cell Lymphoma (RESTART) by Mikhaeel, G., Bourlon, C., Springell, D., Roddie, C., Brady, J.L., De Farias, M. Correia, Sanderson, R., Benjamin, R., Hwang, A., Kamat, S., Courtney, K., Patten, P., Kumar, E., Hardefeldt, P., Yallop, D., Ntentas, G., Keshwani, K., Sivabalasingham, S., Kuhnl, A.

“…Radiotherapy is an accepted bridging prior to CD19 CAR T in large B cell lymphoma (LBCL) and is sometimes used post CAR T for residual disease. However,…”
Get full text

Proton beam therapy for early breast cancer: a systematic review and quantitative synthesis of adverse clinical outcomes by Holt, F., Probert, J., Liu, Z., Duane, F., Ntentas, G., Darby, S., Dodwell, D., Coles, C., Haviland, J., Kirby, A., Taylor, C.

Get full text

An Excess Mortality Risk Analysis of Proton Beam versus Optimal Photon Radiotherapy for Mediastinal Hodgkin Lymphoma: Who May Benefit Most? by Ntentas, G., Dedeckova, K., Andrilik, M., Shakir, R., Aznar, M.C., Ramroth, J., Begum, R., Darby, S., Mikhaeel, G., Cutter, D.

Get full text

OC-0295 Colorectal cancer risk following radiotherapy and procarbazine for Hodgkin lymphoma by Shakir, R., Geurts, Y., Ntentas, G., Aleman, B., Ramroth, J., John, K., Janus, C., Krol, A., Roesink, J., van den Maazen, R., Zijlstra, J., van Leeuwen, F., Cutter, D., Schaapveld, M.

Get full text

Cardiac Radiation Dose Reconstruction in the Study of Late Effects: A Comparison of Different Methods by Ntentas, G., Aznar, M.C., Hodgson, D., Darby, S.C., Ahmed, S., Ng, A., Cutter, D.

Get full text